Table 1 Basline characteristics of the patients (N = 1048).
Characteristic | Uric acid (umol/L) (Tertile) | p value | ||
|---|---|---|---|---|
T1 (8.38–283.90) | T2 (284.60–389.30) | T3 (389.50–986.40) | ||
No. of patients | 349 | 349 | 350 | |
Age (years, mean ± sd) | 51.26 ± 11.90 | 50.11 ± 11.21 | 49.15 ± 11.22 | 0.052 |
Gender (female) | 138 (39.54%) | 73 (20.92%) | 43 (12.29%) | < 0.001 |
BMI (Kg/m2, mean ± sd) | 23.85 ± 4.11 | 25.24 ± 4.66 | 25.95 ± 4.55 | < 0.001 |
Smoking | 85 (24.36%) | 92 (26.36%) | 99 (28.29%) | 0.499 |
Hypertension | 234 (67.05%) | 244 (69.91%) | 248 (70.86%) | 0.524 |
Diabetes | 9 (2.58%) | 8 (2.29%) | 9 (2.57%) | 0.962 |
Marfan syndrome | 8 (2.29%) | 15 (4.30%) | 8 (2.29%) | 0.195 |
Bicuspid aortic valve | 5 (1.43%) | 4 (1.15%) | 2 (0.57%) | 0.523 |
CRI | 9 (2.58%) | 2 (0.57%) | 13 (3.71%) | 0.019 |
Stroke | 11 (3.15%) | 13 (3.72%) | 13 (3.71%) | 0.896 |
Atherosclerosis | 23 (6.59%) | 18 (5.16%) | 18 (5.14%) | 0.635 |
Time to presentation (h, median (Q1–Q3)) | 36.00 (15.00–120.00) | 24.00 (10.00–72.00) | 18.00 (10.00–48.00) | 0.777 |
SBP (mmHg, mean ± sd) | 139.79 ± 28.37 | 139.98 ± 30.65 | 140.14 ± 33.05 | 0.988 |
DBP (mmHg, mean ± sd) | 75.29 ± 18.33 | 75.77 ± 18.29 | 76.80 ± 20.07 | 0.557 |
Aortic diameter (mm) | 44.55 ± 10.97 | 44.68 ± 10.48 | 44.10 ± 10.08 | 0.743 |
Aortic regurgitation | 167 (47.85%) | 155 (44.41%) | 175 (50.00%) | 0.329 |
Abdominal vessel involvement | 131 (37.54%) | 122 (34.96%) | 128 (36.57%) | 0.774 |
Arch vessel involvement | 118 (33.81%) | 111 (31.81%) | 131 (37.43%) | 0.284 |
EF value (%) | 65.24 ± 7.01 | 64.82 ± 8.02 | 63.71 ± 9.26 | 0.037 |
Cr (umol/L median(Q1–Q3)) | 71.30 (54.10–86.30) | 80.30 (65.50–110.00) | 117.45 (83.23–164.88) | < 0.001 |
BUN (mmol/L median(Q1–Q3)) | 6.10 (4.54–8.27) | 6.93 (5.39–9.06) | 8.70 (6.36–13.06) | < 0.001 |
eGFR | 94.30(72.37–124.04) | 91.35(65.03–120.81) | 65.51(42.56–103.19) | < 0.001 |
TG (mmol/L) | 1.45 ± 0.86 | 1.54 ± 1.16 | 1.69 ± 1.35 | 0.019 |
TC (mmol/L) | 3.89 ± 0.99 | 3.97 ± 0.94 | 4.00 ± 0.94 | 0.284 |
HDL (mmol/L) | 1.45 ± 4.61 | 1.14 ± 0.31 | 1.33 ± 4.47 | 0.534 |
LDL (mmol/L) | 2.02 ± 1.78 | 2.13 ± 0.85 | 2.24 ± 0.86 | 0.058 |
D-dimer (ug/mL) | 4.00 (2.30–9.00) | 3.79 (2.25–9.50) | 4.53 (2.74–15.93) | 0.019 |
FDP (ug/mL) | 15.60 (7.60–35.30) | 17.94 (7.49–51.29) | 30.50 (11.65–67.58) | < 0.001 |
CRP (mg/L) | 62.10 (13.10–116.00) | 41.50 (9.72–108.00) | 30.75 (8.23–89.38) | 0.012 |
Operation | 244 (69.91%) | 232 (66.48%) | 207 (59.14%) | 0.009 |
Symptom | 0.948 | |||
Chest pain | 253 (72.49%) | 248 (71.06%) | 250 (71.43%) | |
Back pain | 45 (12.89%) | 47 (13.47%) | 44 (12.57%) | |
Abdominal pain | 12 (3.44%) | 13 (3.72%) | 13 (3.71%) | |
Syncope | 11 (3.15%) | 18 (5.16%) | 12 (3.43%) | |
others | 28 (8.03%) | 23 (6.59%) | 31(8.85%) | |
Coronary malperfusion | 8 (2.29%) | 11 (3.15%) | 40 (11.43%) | < 0.001 |
Mesenteric malperfusion | 5 (1.43%) | 4 (1.15%) | 6 (1.71%) | 0.819 |
Cerebral malperfusion | 11 (3.15%) | 18 (5.16%) | 12 (3.43%) | 0.334 |
Hypotension/shock | 8 (2.29%) | 16 (4.58%) | 20 (5.71%) | 0.071 |
Cardiac tamponade | 2 (0.57%) | 4 (1.15%) | 8 (2.29%) | 0.133 |
Mortality | < 0.001 | |||
Survivor | 267 (76.50%) | 238 (68.19%) | 205 (58.57%) | |
Non-survivor | 82 (23.50%) | 111 (31.81%) | 145 (41.43%) | |
